|
Kala reels in $22.5M to get its next-gen eye drops into PhIII
FierceBiotech Kala also has an early-stage MPP-powered treatment for wet age-related macular degeneration, a drug the company plans to advance toward candidate selection this year. Beyond the potential of any one potential therapy, Kala’s promise lies in its … Kala Pharma Grabs $22.5M More For Eye DrugsXconomy Kala Pharmaceuticals Announces $22.5 Million Series B FinancingBusiness Wire (press release) Kala gets $23M to pay for drug trials in fast-growing eye disease marketBoston Business Journal (blog) |
Source: Wet Macular Degeneration News From Google News
Zennie Abraham | Zennie Abraham or “Zennie62” is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.